OS Therapies (OSTX) Interest & Investment Income (2023 - 2026)

OS Therapies (OSTX) has 4 years of Interest & Investment Income data on file, last reported at $45.0 in Q1 2026.

• Quarterly Interest & Investment Income fell 31.82% year-over-year to $45.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $228.0 (up 240.3% YoY) and the FY2025 annual result came in at $249.0, changed N/A from the prior year.
• Interest & Investment Income declined to $45.0 in Q1 2026, from $54.0 in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $66.0 in Q1 2025 to a low of $1.0 in Q3 2023.
• A 4-year average of $42.29 and a median of $54.0 in 2025 frame the typical range for Interest & Investment Income.
• Annual changes were most pronounced in 2025 — Interest & Investment Income jumped 6300.0% — and 2026, when it sank 31.82%.
• Tracing OSTX's Interest & Investment Income over 4 years: stood at $1.0 in 2023, then changed by 0.0% to $1.0 in 2024, then jumped by 5300.0% to $54.0 in 2025, then fell by 16.67% to $45.0 in 2026.
• The last three Interest & Investment Income figures came in at $45.0 (Q1 2026), $54.0 (Q4 2025), and $65.0 (Q3 2025), per Business Quant data.